These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 35705463)
1. [Clinical characteristics and long-term follow-up results of radiofrequency ablation for the treatment of ventricular tachycardia in patients with arrhythmogenic left ventricular cardiomyopathy]. Wang Z; Shi LS; Liu HL; Wang ZZ; Jiang XH; Chen HW; Yang G; Gu K; Ju WZ; Chen M Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jun; 50(6):549-555. PubMed ID: 35705463 [No Abstract] [Full Text] [Related]
2. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach. Mathew S; Saguner AM; Schenker N; Kaiser L; Zhang P; Yashuiro Y; Lemes C; Fink T; Maurer T; Santoro F; Wohlmuth P; Reißmann B; Heeger CH; Tilz R; Wissner E; Rillig A; Metzner A; Kuck KH; Ouyang F J Am Heart Assoc; 2019 Mar; 8(5):e010365. PubMed ID: 30813830 [TBL] [Abstract][Full Text] [Related]
3. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation? Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527 [TBL] [Abstract][Full Text] [Related]
4. Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar. Liuba I; Muser D; Chahal A; Tschabrunn C; Santangeli P; Kuo L; Frankel DS; Callans DJ; Garcia F; Supple GE; Schaller RD; Dixit S; Lin D; Nazarian S; Kumareswaran R; Arkles J; Riley MP; Hyman MC; Walsh K; Guandalini G; Arceluz M; Pothineni NVK; Zado ES; Marchlinski F Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010279. PubMed ID: 34847692 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study. Pisani CF; Romero J; Lara S; Hardy C; Chokr M; Sacilotto L; Wu TC; Darrieux F; Hachul D; Kalil-Filho R; Di Biase L; Scanavacca M Heart Rhythm; 2020 Sep; 17(9):1510-1518. PubMed ID: 32087356 [TBL] [Abstract][Full Text] [Related]
6. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study. Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051 [TBL] [Abstract][Full Text] [Related]
7. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346 [TBL] [Abstract][Full Text] [Related]
9. [Radiofrequency catheter ablation of ventricular tachycardia in patients post surgical repair of tetralogy of Fallot]. Wang P; Wu LM; Zheng LH; Chen G; Niu GD; Yao Y Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jun; 49(6):615-620. PubMed ID: 34126730 [No Abstract] [Full Text] [Related]
10. Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy and biventricular involvement. Shen L; Liu S; Zhang Z; Xiong Y; Lai Z; Hu F; Zheng L; Yao Y Europace; 2024 Mar; 26(3):. PubMed ID: 38417843 [TBL] [Abstract][Full Text] [Related]
11. Epicardial only mapping and ablation of ventricular tachycardia: a case series. Berte B; Yamashita S; Sacher F; Cochet H; Hooks D; Aljefairi N; Amraoui S; Denis A; Derval N; Hocini M; Haïssaguerre M; Jaïs P Europace; 2016 Feb; 18(2):267-73. PubMed ID: 25840285 [TBL] [Abstract][Full Text] [Related]
13. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness. Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940 [TBL] [Abstract][Full Text] [Related]
14. Catheter ablation of subepicardial ventricular tachycardia using electroanatomic mapping. Ouyang F; Bänsch D; Schaumann A; Ernst S; Linder C; Falk P; Hachiya H; Kuck KH; Antz M Herz; 2003 Nov; 28(7):591-7. PubMed ID: 14689119 [TBL] [Abstract][Full Text] [Related]
15. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503 [TBL] [Abstract][Full Text] [Related]